JP2015096530A5 - - Google Patents

Download PDF

Info

Publication number
JP2015096530A5
JP2015096530A5 JP2014251851A JP2014251851A JP2015096530A5 JP 2015096530 A5 JP2015096530 A5 JP 2015096530A5 JP 2014251851 A JP2014251851 A JP 2014251851A JP 2014251851 A JP2014251851 A JP 2014251851A JP 2015096530 A5 JP2015096530 A5 JP 2015096530A5
Authority
JP
Japan
Prior art keywords
equivalent
effect
amount
present
proportions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014251851A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015096530A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2015096530A publication Critical patent/JP2015096530A/ja
Publication of JP2015096530A5 publication Critical patent/JP2015096530A5/ja
Pending legal-status Critical Current

Links

JP2014251851A 2008-09-05 2014-12-12 医薬配合剤 Pending JP2015096530A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08015625.0 2008-09-05
EP08015625 2008-09-05

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011525465A Division JP5731387B2 (ja) 2008-09-05 2009-09-04 医薬配合剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016240032A Division JP2017071636A (ja) 2008-09-05 2016-12-12 医薬配合剤

Publications (2)

Publication Number Publication Date
JP2015096530A JP2015096530A (ja) 2015-05-21
JP2015096530A5 true JP2015096530A5 (enExample) 2016-06-16

Family

ID=40345058

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2011525465A Active JP5731387B2 (ja) 2008-09-05 2009-09-04 医薬配合剤
JP2014251851A Pending JP2015096530A (ja) 2008-09-05 2014-12-12 医薬配合剤
JP2016240032A Pending JP2017071636A (ja) 2008-09-05 2016-12-12 医薬配合剤
JP2019070282A Pending JP2019131578A (ja) 2008-09-05 2019-04-02 医薬配合剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2011525465A Active JP5731387B2 (ja) 2008-09-05 2009-09-04 医薬配合剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2016240032A Pending JP2017071636A (ja) 2008-09-05 2016-12-12 医薬配合剤
JP2019070282A Pending JP2019131578A (ja) 2008-09-05 2019-04-02 医薬配合剤

Country Status (28)

Country Link
US (1) US20100063148A1 (enExample)
EP (2) EP2331210B1 (enExample)
JP (4) JP5731387B2 (enExample)
KR (3) KR101730924B1 (enExample)
CN (2) CN105520924B (enExample)
AR (2) AR073361A1 (enExample)
AU (3) AU2009289776A1 (enExample)
BR (1) BRPI0920521A2 (enExample)
CA (1) CA2735857C (enExample)
CL (1) CL2011000317A1 (enExample)
CO (1) CO6382142A2 (enExample)
CY (2) CY1115751T1 (enExample)
DK (2) DK2331210T3 (enExample)
EC (1) ECSP11010869A (enExample)
ES (2) ES2513394T3 (enExample)
HR (2) HRP20140663T1 (enExample)
HU (1) HUE043278T2 (enExample)
IL (3) IL211135A (enExample)
LT (1) LT2735338T (enExample)
MX (1) MX2011002339A (enExample)
PE (5) PE20110291A1 (enExample)
PL (2) PL2331210T3 (enExample)
PT (2) PT2331210E (enExample)
RU (2) RU2571501C2 (enExample)
SI (2) SI2331210T1 (enExample)
TR (1) TR201904388T4 (enExample)
WO (1) WO2010025931A2 (enExample)
ZA (1) ZA201101449B (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060159743A1 (en) * 2001-10-25 2006-07-20 Depomed, Inc. Methods of treating non-nociceptive pain states with gastric retentive gabapentin
TWI312285B (en) 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
US7612112B2 (en) 2001-10-25 2009-11-03 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
US20090176882A1 (en) 2008-12-09 2009-07-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
PL2462990T3 (pl) 2006-06-15 2014-05-30 Ucb Pharma Gmbh Kompozycja farmaceutyczna obejmująca lakozamid i lewetyracetam o synergistycznym działaniu przeciwdrgawkowym
US20100190752A1 (en) 2008-09-05 2010-07-29 Gruenenthal Gmbh Pharmaceutical Combination
LT2735338T (lt) * 2008-09-05 2019-04-10 Grünenthal GmbH 3-(3-dimetilamino-1-etil-2-metil-propil)-fenolio ir pregabalino arba gabapentino farmacinis derinys
FR2943246B1 (fr) * 2009-03-19 2011-07-29 Biocodex Compose pour son utilisation dans le traitement des neuropathies peripheriques
AU2011267474B2 (en) * 2010-06-15 2016-05-26 Grünenthal GmbH Pharmaceutical combination for the treatment of pain
EP2590636A1 (en) 2010-07-06 2013-05-15 Grünenthal GmbH Novel gastro- retentive dosage forms comprising a gaba analog and an opioid
JP5786714B2 (ja) 2010-07-30 2015-09-30 東レ株式会社 神経障害性疼痛の治療剤又は予防剤
EA028149B1 (ru) * 2011-03-04 2017-10-31 Грюненталь Гмбх Парентеральное введение тапентадола
ES2712072T3 (es) * 2011-07-20 2019-05-09 Torrent Pharmaceuticals Ltd Composición farmacéutica de tapentadol
PT2736501T (pt) * 2011-07-29 2018-03-26 Gruenenthal Gmbh Administração intratecal ou epidural de 3-[(1s,2s)-3-(dimetilamino)-1-etil-2-metilpropil]fenol
US20130310385A1 (en) 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants
US9345689B2 (en) * 2012-05-18 2016-05-24 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N, N-dimethyl-4-phenyl-4,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and an anticonvulsant
US8912226B2 (en) * 2012-05-18 2014-12-16 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r) -6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a NSAR
US20130310435A1 (en) * 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol
US9855286B2 (en) * 2012-05-18 2018-01-02 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component
US9308196B2 (en) * 2012-05-18 2016-04-12 Gruenenthal Gmbh Pharmaceutical composition comprising (1 r,4r) -6'-fluoro-N ,N-dimethyl-4-phenyl-4',9'-d ihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and an oxicam
US9320729B2 (en) 2012-05-18 2016-04-26 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
US9320725B2 (en) 2012-05-18 2016-04-26 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a gabapentinoid
US9629818B2 (en) * 2012-11-01 2017-04-25 Torrent Pharmaceuticals Ltd. Pharmaceutical composition of tapentadol for parenteral administration
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
US9549909B2 (en) 2013-05-03 2017-01-24 The Katholieke Universiteit Leuven Method for the treatment of dravet syndrome
CN103655523A (zh) * 2013-12-24 2014-03-26 南京艾德凯腾生物医药有限责任公司 他喷他多组合物
RU2020128323A (ru) 2015-12-22 2020-10-06 Зодженикс Интернэшнл Лимитед Фенфлураминовые композиции и способы их получения
EP3393470B1 (en) 2015-12-22 2021-01-20 Zogenix International Limited Metabolism resistant fenfluramine analogs and methods of using the same
KR20250040753A (ko) * 2016-08-24 2025-03-24 조게닉스 인터내셔널 리미티드 5-ht2b 작용물질의 형성을 억제하기 위한 제제 및 그것의 사용 방법
US10682317B2 (en) 2017-09-26 2020-06-16 Zogenix International Limited Ketogenic diet compatible fenfluramine formulation
KR20190081385A (ko) 2017-12-29 2019-07-09 강원대학교산학협력단 옥스카바제핀을 유효성분으로 함유하는 허혈성 뇌혈관 질환 예방용 조성물
EP3790537A1 (en) 2018-05-11 2021-03-17 Zogenix International Limited Compositions and methods for treating seizure-induced sudden death
EP3883555A1 (en) 2018-11-19 2021-09-29 Zogenix International Limited Methods of treating rett syndrome using fenfluramine
US11612574B2 (en) 2020-07-17 2023-03-28 Zogenix International Limited Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4612008A (en) 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US5472711A (en) 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
US5330761A (en) 1993-01-29 1994-07-19 Edward Mendell Co. Inc. Bioadhesive tablet for non-systemic use products
US5455046A (en) 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5399362A (en) 1994-04-25 1995-03-21 Edward Mendell Co., Inc. Once-a-day metoprolol oral dosage form
DE4426245A1 (de) 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
JP4977297B2 (ja) * 1999-08-20 2012-07-18 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド トラマドール物質及び抗痙攣薬を含んで成る組成物
AU2003210486B2 (en) * 2002-01-16 2007-06-28 Endo Pharmaceuticals Inc. Pharmaceutical composition and method for treating disorders of the central nervous system
IL162932A0 (en) * 2002-02-22 2005-11-20 Warner Lambert Co Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2
WO2007005716A2 (en) 2005-06-30 2007-01-11 Cinergen, Llc Methods of treatment and compositions for use thereof
WO2007087452A2 (en) * 2006-01-27 2007-08-02 Theraquest Biosciences, Llc Abuse resistant and extended release formulations and method of use thereof
MX2008013828A (es) * 2006-04-28 2008-11-10 Gruenenthal Gmbh Combinacion farmaceutica que comprende 3-(3-dimetilanimo-1-etil-2- metil-propil)-fenol y un nsaid.
WO2008027442A2 (en) * 2006-08-30 2008-03-06 Theraquest Biosciences, Llc Abuse deterrent oral pharmaceutical formulations of opioid agonists and method of use
WO2009067703A2 (en) * 2007-11-23 2009-05-28 Nectid, Inc. Tapentadol compositions
JP5291123B2 (ja) * 2008-01-25 2013-09-18 ゼノポート，インコーポレイティド （３ｓ）−アミノメチル−５−ヘキサン酸プロドラッグの結晶形態及びその使用
LT2735338T (lt) * 2008-09-05 2019-04-10 Grünenthal GmbH 3-(3-dimetilamino-1-etil-2-metil-propil)-fenolio ir pregabalino arba gabapentino farmacinis derinys

Similar Documents

Publication Publication Date Title
JP2015096530A5 (enExample)
JP2018533683A5 (enExample)
PH12016501873A1 (en) Anti-influenza b virus hemagglutinin antibodies and methods of use
JP2015207624A5 (enExample)
JP2014235432A5 (enExample)
JP2015186128A5 (enExample)
JP2015173751A5 (enExample)
JP2015016294A5 (enExample)
EA201691792A1 (ru) Фармацевтические составы на основе вилдаглиптина
JP2019094312A5 (enExample)
LT3097921T (lt) Kompozicijos, apimančios geraniolį ir sausą imbierą, skirtos naudoti dirgliosios žarnos sindromo gydymui
PH12017501943A1 (en) Influenza virus neutralizing peptidomimetic compounds
JP2016140650A5 (enExample)
CN302524916S (zh) 包装瓶（五倍子花粉）
CN302576556S (zh) 角磨机
CN302559847S (zh) 输入装置
CN302548735S (zh) 酱料瓶
CN302421118S (zh) 电钻
CN302543740S (zh) 洗涤水嘴（xg827）
CN302543741S (zh) 洗涤水嘴（xg826）
CN302429069S (zh) 包装盒（新开河“府”参）
CN302540259S (zh) 单连组合式家具（m05）
CN302488257S (zh) 包装盒（1）
CN302429068S (zh) 包装盒（新开河“国”参）
JP2015522004A5 (enExample)